
John Newman
Stock Analyst at Canaccord Genuity
(0.10)
# 4,885
Out of 5,189 analysts
984
Total ratings
36%
Success rate
-8.8%
Average return
Main Sectors:
Stocks Rated by John Newman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INCY Incyte | Reiterated: Buy | $152 | $114.63 | +32.61% | 7 | Nov 17, 2026 | |
| TNGX Tango Therapeutics | Reiterated: Buy | $46 | $21.73 | +111.69% | 18 | Nov 17, 2026 | |
| CADL Candel Therapeutics | Reiterated: Buy | $25 → $13 | $5.04 | +157.94% | 14 | Nov 13, 2026 | |
| PBLS Parabilis Medicines | Reiterated: Buy | $39 | $27.44 | +42.13% | 2 | Nov 13, 2026 | |
| BBOT BridgeBio Oncology Therapeutics | Reiterated: Buy | $20 | $1.81 | +1,004.97% | 6 | Nov 12, 2026 | |
| TYRA Tyra Biosciences | Reiterated: Buy | $50 | $20.12 | +148.51% | 18 | Nov 11, 2026 | |
| ALLO Allogene Therapeutics | Reiterated: Buy | $14 | $0.6277 | +2,130.36% | 41 | Nov 10, 2026 | |
| ATRA Atara Biotherapeutics | Reiterated: Buy | $13 | $6.33 | +105.37% | 94 | Nov 10, 2026 | |
| CMPX Compass Therapeutics | Reiterated: Buy | $7 | $0.6882 | +917.15% | 18 | Nov 10, 2026 | |
| DCTH Delcath Systems | Reiterated: Buy | $21 → $27 | $18.79 | +43.69% | 32 | Nov 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1,175 | $920.69 | +27.62% | 121 | Nov 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $33.26 | +20.26% | 15 | Nov 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 | $2.14 | +741.12% | 35 | Nov 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $29 | $16.12 | +79.90% | 4 | Nov 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $132 | $80.96 | +63.04% | 34 | Nov 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 | $1.24 | +1,674.19% | 70 | Nov 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $29 | $4.92 | +489.43% | 3 | Nov 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $1.09 | +633.94% | 16 | Oct 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $0.7719 | +1,065.95% | 3 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $3.99 | n/a | 18 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $0.3501 | n/a | 19 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 → $300 | $4.58 | n/a | 34 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $43 | $6.14 | n/a | 45 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $52 → $44 | $27.60 | n/a | 57 | Feb 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 → $3 | $0.0002 | n/a | 24 | Aug 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $353.03 | $21.04 | n/a | 2 | May 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $31 | $7.56 | n/a | 1 | May 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 | $13.22 | n/a | 25 | May 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $0.3369 | n/a | 12 | Mar 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14.35 | $9.24 | n/a | 1 | Mar 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $0.84 | n/a | 18 | Jun 26, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $31 → $6 | $1.01 | n/a | 18 | Aug 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $5 | $37.04 | n/a | 17 | Jun 27, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $14.70 | n/a | 10 | Mar 10, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $13.00 | n/a | 11 | Mar 1, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $6.99 | n/a | 12 | Dec 30, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 → $60 | $0.40745 | n/a | 13 | Nov 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 → $15 | $1.48 | n/a | 4 | Oct 11, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $34 | $8.76 | n/a | 17 | Aug 10, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 | $4.26 | n/a | 9 | Jul 26, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $90 | $29.63 | n/a | 1 | Jun 13, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $1.95 | n/a | 1 | May 13, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 | $27.57 | n/a | 1 | May 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 | $594.51 | n/a | 1 | Mar 31, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $8 → $6 | $0.7852 | n/a | 5 | Mar 9, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $201 | $230.26 | n/a | 5 | Mar 3, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $24 | $5.82 | n/a | 1 | Jan 7, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $40 → $9 | $7.45 | n/a | 3 | Oct 7, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $127 | $249.59 | n/a | 45 | Dec 20, 2011 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $5 | $3.85 | n/a | 2 | Mar 15, 2010 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $72.11 | n/a | 1 | Jun 10, 2009 |
Incyte
Nov 17, 2026
Reiterated: Buy
Price Target: $152
Current: $114.63
Upside: +32.61%
Tango Therapeutics
Nov 17, 2026
Reiterated: Buy
Price Target: $46
Current: $21.73
Upside: +111.69%
Candel Therapeutics
Nov 13, 2026
Reiterated: Buy
Price Target: $25 → $13
Current: $5.04
Upside: +157.94%
Parabilis Medicines
Nov 13, 2026
Reiterated: Buy
Price Target: $39
Current: $27.44
Upside: +42.13%
BridgeBio Oncology Therapeutics
Nov 12, 2026
Reiterated: Buy
Price Target: $20
Current: $1.81
Upside: +1,004.97%
Tyra Biosciences
Nov 11, 2026
Reiterated: Buy
Price Target: $50
Current: $20.12
Upside: +148.51%
Allogene Therapeutics
Nov 10, 2026
Reiterated: Buy
Price Target: $14
Current: $0.6277
Upside: +2,130.36%
Atara Biotherapeutics
Nov 10, 2026
Reiterated: Buy
Price Target: $13
Current: $6.33
Upside: +105.37%
Compass Therapeutics
Nov 10, 2026
Reiterated: Buy
Price Target: $7
Current: $0.6882
Upside: +917.15%
Delcath Systems
Nov 10, 2026
Reiterated: Buy
Price Target: $21 → $27
Current: $18.79
Upside: +43.69%
Nov 10, 2026
Reiterated: Buy
Price Target: $1,175
Current: $920.69
Upside: +27.62%
Nov 10, 2026
Reiterated: Buy
Price Target: $40
Current: $33.26
Upside: +20.26%
Nov 6, 2026
Reiterated: Buy
Price Target: $18
Current: $2.14
Upside: +741.12%
Nov 5, 2026
Reiterated: Buy
Price Target: $29
Current: $16.12
Upside: +79.90%
Nov 4, 2026
Reiterated: Buy
Price Target: $132
Current: $80.96
Upside: +63.04%
Nov 4, 2026
Reiterated: Buy
Price Target: $22
Current: $1.24
Upside: +1,674.19%
Nov 3, 2026
Reiterated: Buy
Price Target: $29
Current: $4.92
Upside: +489.43%
Oct 20, 2026
Reiterated: Buy
Price Target: $8
Current: $1.09
Upside: +633.94%
Aug 6, 2026
Reiterated: Buy
Price Target: $9
Current: $0.7719
Upside: +1,065.95%
Nov 12, 2024
Reiterated: Buy
Price Target: $10
Current: $3.99
Upside: n/a
Nov 12, 2024
Reiterated: Buy
Price Target: $5
Current: $0.3501
Upside: n/a
Oct 1, 2024
Reiterated: Buy
Price Target: $6 → $300
Current: $4.58
Upside: n/a
Aug 8, 2024
Reiterated: Buy
Price Target: $43
Current: $6.14
Upside: n/a
Feb 16, 2022
Reiterated: Buy
Price Target: $52 → $44
Current: $27.60
Upside: n/a
Aug 17, 2021
Reiterated: Buy
Price Target: $7 → $3
Current: $0.0002
Upside: n/a
May 26, 2021
Reiterated: Buy
Price Target: $353.03
Current: $21.04
Upside: n/a
May 12, 2021
Reiterated: Buy
Price Target: $31
Current: $7.56
Upside: n/a
May 3, 2021
Reiterated: Buy
Price Target: $45
Current: $13.22
Upside: n/a
Mar 25, 2021
Reiterated: Buy
Price Target: $5
Current: $0.3369
Upside: n/a
Mar 9, 2020
Reiterated: Buy
Price Target: $14.35
Current: $9.24
Upside: n/a
Jun 26, 2019
Reiterated: Buy
Price Target: $20
Current: $0.84
Upside: n/a
Aug 13, 2018
Reiterated: Buy
Price Target: $31 → $6
Current: $1.01
Upside: n/a
Jun 27, 2017
Reiterated: Buy
Price Target: $8 → $5
Current: $37.04
Upside: n/a
Mar 10, 2017
Reiterated: Buy
Price Target: $10
Current: $14.70
Upside: n/a
Mar 1, 2017
Reiterated: Buy
Price Target: $12
Current: $13.00
Upside: n/a
Dec 30, 2016
Reiterated: Buy
Price Target: $10
Current: $6.99
Upside: n/a
Nov 9, 2016
Reiterated: Buy
Price Target: $6 → $60
Current: $0.40745
Upside: n/a
Oct 11, 2016
Reiterated: Buy
Price Target: $6 → $15
Current: $1.48
Upside: n/a
Aug 10, 2016
Reiterated: Buy
Price Target: $34
Current: $8.76
Upside: n/a
Jul 26, 2016
Reiterated: Buy
Price Target: $3
Current: $4.26
Upside: n/a
Jun 13, 2016
Reiterated: Hold
Price Target: $90
Current: $29.63
Upside: n/a
May 13, 2016
Reiterated: Buy
Price Target: $30
Current: $1.95
Upside: n/a
May 2, 2016
Reiterated: Buy
Price Target: $26
Current: $27.57
Upside: n/a
Mar 31, 2016
Reiterated: Buy
Price Target: $18
Current: $594.51
Upside: n/a
Mar 9, 2015
Reiterated: Hold
Price Target: $8 → $6
Current: $0.7852
Upside: n/a
Mar 3, 2015
Reiterated: Buy
Price Target: $201
Current: $230.26
Upside: n/a
Jan 7, 2015
Initiated Coverage: Buy
Price Target: $24
Current: $5.82
Upside: n/a
Oct 7, 2014
Downgraded: Hold
Price Target: $40 → $9
Current: $7.45
Upside: n/a
Dec 20, 2011
Rated: Buy
Price Target: $127
Current: $249.59
Upside: n/a
Mar 15, 2010
Downgraded: Sell
Price Target: $5
Current: $3.85
Upside: n/a
Jun 10, 2009
Reiterated: Sell
Price Target: n/a
Current: $72.11
Upside: n/a